Cetilistat CAS 282526-98-1: A Novel Pancreatic Lipase Inhibitor for Obesity Treatment

Explore the cutting-edge research and potential applications of Cetilistat, a powerful pancreatic lipase inhibitor. Discover its role in combating obesity and advancing metabolic research as a high-quality pharmaceutical intermediate from trusted suppliers.

Get a Quote & Sample

Advantages Provided by the Product

Potent Lipase Inhibition

Cetilistat exhibits significant potency in inhibiting pancreatic lipase, making it a valuable tool for research into fat metabolism and obesity, directly supporting the exploration of how does Cetilistat work.

Key for Obesity Treatment Research

As a primary compound for studying anti-obesity mechanisms, Cetilistat is essential for researchers aiming to develop effective weight management strategies, aligning with Cetilistat obesity treatment goals.

Reliable Pharmaceutical Intermediate

Supplied as a high-purity chemical, Cetilistat serves as a dependable intermediate for further synthesis and drug development, crucial for advancing Cetilistat pharmaceutical applications.

Key Applications

Obesity Treatment Research

Cetilistat is a cornerstone for research aiming to understand and treat obesity by modulating fat absorption, a key area in metabolic disorder studies.

Enzyme Inhibition Studies

Its specific action against pancreatic lipase makes it an ideal compound for in-depth enzyme kinetics and inhibition mechanism studies.

Pharmaceutical Intermediate Synthesis

Cetilistat serves as a vital building block in the synthesis of more complex pharmaceutical compounds for therapeutic development.

Metabolic Health Research

The compound is instrumental in researching lipid profiles, fat metabolism, and their overall impact on metabolic health.